Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Copernicus’ Nanoparticle Technology Applied to siRNA

Abstract:
Copernicus Therapeutics, Inc. announced today that at the American Society of Gene Therapy (ASGT) Meeting held in Seattle, Washington, Copernicus showed that the methods used to produce DNA nanoparticles were also very effective when applied to siRNA. Both DNA nanoparticles as well as nanoparticles made with siRNA are highly resistant to degradative processes that would destroy the therapeutic benefit of the nanoparticles. These findings are significant because siRNAs can be designed to block the expression of specific genes and have the potential to treat numerous human diseases, including viral infections. A 2006 Nobel Prize was awarded to the scientists that discovered siRNA.

Copernicus’ Nanoparticle Technology Applied to siRNA

Cleveland, OH | Posted on June 5th, 2007

"We are most enthusiastic about these findings," said Dr. Mark J. Cooper, Sr. Vice President of Science and Medical Affairs at Copernicus. "Our non-viral nucleic acid delivery system provides important safety and efficacy characteristics not seen with viral-based systems. We have extensive experience in the development of DNA nanoparticles, including an encouraging clinical trial in subjects with cystic fibrosis. The data presented at ASGT show that we may be able to expand the use of our non-viral nucleic acid delivery system to the exciting field of siRNA. These results have encouraged us and others to explore the use of our siRNA delivery platform to treat a variety of serious diseases."

"These findings further demonstrate the platform nature of our nucleic acid nanoparticle technology which enables us to develop nucleic acid therapeutics for different parts of the body and for multiple diseases," said Dr. Robert C. Moen, President and CEO of Copernicus. "Our lead DNA nanoparticle program is developing a therapy for a serious disease affecting the lung, cystic fibrosis. Opportunities for siRNA nanoparticles are numerous, and include serious viral lung infections and other genetic disorders."

####

About Copernicus Therapeutics, Inc.
Copernicus Therapeutics, Inc., a privately held biotechnology company, is advancing novel nucleic acid delivery systems with broad applications in human therapeutics. The Company’s delivery platform can be used to enhance the efficacy and safety of existing drugs as well as to create novel therapeutics.

For more information, please click here

Contacts:
Copernicus Therapeutics, Inc.
Robert C. Moen, M.D., Ph.D., 216-231-0227 x26
President and CEO

or
Mark J. Cooper, M.D., 216-231-0227 x23
Sr VP, Science and Medical Affairs

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015

Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015

Seeing the action: UCSB researchers develop a novel device to image the minute forces and actions involved in cell membrane hemifusion May 27th, 2015

Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015

Announcements

Stanford breakthrough heralds super-efficient light-based computers: Light can transmit more data while consuming far less power than electricity, and an engineering feat brings optical data transport closer to replacing wires May 29th, 2015

Donuts, math, and superdense teleportation of quantum information May 29th, 2015

OSU researchers prove magnetism can control heat, sound: Team leverages OSC services to help confirm, interpret experimental findings May 29th, 2015

Two UCSB Professors Receive Early Career Research Awards: The Department of Energy’s award for young scientists acknowledges UC Santa Barbara’s standing as a top tier research institution May 29th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project